SLC6A3 and Cognitive impairment: We have compared the altered proteins expressed in the PBWCs in two categories of patients different severity of cognitive deficits, namely patients with mild cognitive impairment (MCI) and patients with full-blown DAT in respect to healthy controls (CTR) in order to understand which are the most important processes involved in the onset and progression of the disease.